Skip to main content
UniHealth

Doctor search

Kathryn Dolores Simms, NP

Nurse Practitioner · Stanford

NPI 1447770359

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
Not verified
Not the same as out of network.
Office
1

Offices

1 location · Stanford Health Care · 3,152 clinicians in this group

Looking this up.

Hospitals listed: Eden Medical Center · Stanford Health Care · Stanford Health Care Tri-Valley. That is not proof they admit you there this week.

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Kathryn Dolores Simms’s office at (650) 723-4000 to ask if they take your plan before you enroll.

Hospitals they work in

3 hospitals

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Eden Medical CenterCastro Valley, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 75% would definitely recommend it
    Overall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.122, Oct 2024 – Sep 2025
  • Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
    Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
  • Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend it
    Overall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for Eden Medical Center

Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 7 the same, 0 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Eden Medical Center
Clostridium Difficile (C.Diff)Infections0.122BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths0.88 (0 to 1.89) · 819 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.81 (0.46 to 1.16)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths137.41 (92.94 to 181.88) · 70 casesNo differentJul 2022 – Jun 2024
Death rate for COPD patientsComplications and deaths8.4 · 78 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths11.7 · 38 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths11.1 · 207 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths17.6 · 359 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths10.5 · 355 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths3.4 · 1,714 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.17 (0 to 0.39) · 4,697 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.3 (0.1 to 0.5) · 4,676 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths2.69 (0.53 to 4.85) · 860 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.56 (0 to 3.24) · 251 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.75 (1.17 to 4.32) · 818 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths7.76 (0 to 15.78) · 261 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths6.09 (2.08 to 10.1) · 242 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.64 (0.16 to 3.12) · 233 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.16 (0 to 0.85) · 4,132 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.9 · 60 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.431No differentOct 2024 – Sep 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.292No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.307No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.61No differentOct 2024 – Sep 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits22.1 · 258 casesNoneJul 2023 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits22.6 · 225 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits2.4 · 367 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.9 · 390 casesNoneJul 2023 – Jun 2025
Rate of readmission after hip/knee replacementUnplanned return visits5.7 · 58 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits20 · 88 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.9 (9.6 to 17.4) · 68 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.8 (0.6 to 1.1) · 205 casesNo differentJan 2024 – Dec 2024

What patients said (431 patients answered, 17% of those asked)

Patient survey stars by topic at Eden Medical Center
Cleanliness3
Nurse communication2
Doctor communication2
Communication about medicines2
Discharge information3
Overall hospital rating3
Quietness3
Recommend hospital4
Share of patients giving the best answer at Eden Medical Center
Room was "always" clean71%
Nurses "always" communicated well75%
Doctors "always" communicated well75%
Staff "always" explained57%
Yes, staff "did" give patients this information87%
Yes, staff "did" give patients information about help after discharge86%
Doctors "always" explained things so they could understand70%
Doctors "always" listened carefully73%
Doctors "always" treated them with courtesy and respect82%
Patients who gave a rating of "9" or "10" (high)70%
Staff "always" explained new medications70%
Nurses "always" explained things so they could understand69%
Nurses "always" listened carefully71%
Nurses "always" treated them with courtesy and respect83%
"Always" quiet at night58%
"YES", patients would definitely recommend the hospital75%
Staff "always" explained possible side effects43%
Yes, staff "did" give patients information about possible symptoms87%
See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths5.31 (4.24 to 6.37) · 8,661 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits14.1 (12.7 to 15.7) · 2,191 casesWorseJan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths4.08 (1.95 to 6.21) · 5,296 casesBetterJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.317BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.446BetterOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.241BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.7 (0.6 to 0.9) · 3,348 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.06 (0.45 to 1.67) · 5,374 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.86 (0.72 to 1)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths166.09 (137.88 to 194.3) · 470 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.1 · 192 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths6.4 · 146 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths9.7 · 253 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.3 · 880 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 935 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.7 · 501 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.1 · 7,730 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.13 (0 to 0.27) · 20,799 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.28 (0.14 to 0.43) · 23,182 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.94 (0.2 to 1.68) · 5,694 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.36 (1.54 to 3.19) · 7,846 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.2 (3.76 to 6.64) · 5,603 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.38 (0.23 to 2.53) · 2,211 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.52 (0.21 to 0.83) · 19,915 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.6 · 416 casesNoneApr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.869No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.857No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.368No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16.2 · 247 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.5 · 1,021 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits47.8 · 258 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-1.6 · 990 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits20.8 · 976 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.5 · 959 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.2 (4.4 to 6.2) · 2,191 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.1 · 425 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits9.6 · 158 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.6 · 183 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.7 (10.4 to 15.4) · 4,578 casesNo differentJan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Patient survey stars by topic at Stanford Health Care
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at Stanford Health Care
Room was "always" clean75%
Nurses "always" communicated well82%
Doctors "always" communicated well81%
Staff "always" explained63%
Yes, staff "did" give patients this information89%
Yes, staff "did" give patients information about help after discharge89%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully80%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)79%
Staff "always" explained new medications76%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully79%
Nurses "always" treated them with courtesy and respect88%
"Always" quiet at night53%
"YES", patients would definitely recommend the hospital83%
Staff "always" explained possible side effects50%
Yes, staff "did" give patients information about possible symptoms90%
See every measure and the patient survey for Stanford Health Care Tri-Valley

Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care Tri-Valley
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.178BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.237BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths0.79 (0 to 1.73) · 1,041 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.79 (0.5 to 1.08)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths145.81 (96.5 to 195.12) · 72 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths2.9 · 55 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths8.6 · 92 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths12.5 · 96 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths9.5 · 395 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 391 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths10.1 · 162 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths3 · 1,736 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.16 (0 to 0.37) · 4,425 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.22 (0.02 to 0.41) · 4,771 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths3.45 (1.46 to 5.44) · 1,403 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.5 (0.05 to 2.94) · 645 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths1.81 (0.38 to 3.24) · 1,279 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths8.53 (3.2 to 13.85) · 639 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.15 (1.89 to 8.41) · 648 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.61 (0.14 to 3.07) · 370 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.16 (0 to 0.83) · 4,160 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths4 · 74 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.369No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections1.112No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits13.1 · 110 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.1 · 437 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits-5.8 · 94 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-19.3 · 456 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits-0.3 · 402 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits15.8 · 358 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits6.8 (4.7 to 9.6) · 198 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits10.1 (7.5 to 13.6) · 198 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.3 · 80 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits10.9 · 46 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.3 · 92 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.4 (9.6 to 16.2) · 1,532 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits1 (0.8 to 1.2) · 929 casesNo differentJan 2024 – Dec 2024

What patients said (1,268 patients answered, 26% of those asked)

Patient survey stars by topic at Stanford Health Care Tri-Valley
Cleanliness3
Nurse communication3
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating3
Quietness2
Recommend hospital4
Share of patients giving the best answer at Stanford Health Care Tri-Valley
Room was "always" clean65%
Nurses "always" communicated well77%
Doctors "always" communicated well79%
Staff "always" explained58%
Yes, staff "did" give patients this information88%
Yes, staff "did" give patients information about help after discharge88%
Doctors "always" explained things so they could understand74%
Doctors "always" listened carefully78%
Doctors "always" treated them with courtesy and respect86%
Patients who gave a rating of "9" or "10" (high)70%
Staff "always" explained new medications72%
Nurses "always" explained things so they could understand73%
Nurses "always" listened carefully74%
Nurses "always" treated them with courtesy and respect84%
"Always" quiet at night42%
"YES", patients would definitely recommend the hospital74%
Staff "always" explained possible side effects44%
Yes, staff "did" give patients information about possible symptoms89%

Original Medicare doctor bills

$2,000,473

Medicare paid this office $2,000,473 for 355 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Injection, pembrolizumab, 1 mg15$545,541None
Injection, darbepoetin alfa, 1 microgram (non-esrd use)44$79,656None
Injection, denosumab, 1 mg22$74,725None
Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg12$48,083None
Injection, ferric carboxymaltose, 1 mg30$27,084None
See all 34 services
Every Original Medicare service billed
Injection, pembrolizumab, 1 mg15$545,541None
Injection, darbepoetin alfa, 1 microgram (non-esrd use)44$79,656None
Injection, denosumab, 1 mg22$74,725None
Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg12$48,083None
Injection, ferric carboxymaltose, 1 mg30$27,084None
Administration of chemotherapy into vein, 1 hour or less57$23,160$118
Injection, pegfilgrastim, excludes biosimilar, 0.5 mg17$17,600None
Short return visit (20+ min)89$10,227$72
Leuprolide acetate (for depot suspension), 7.5 mg15$9,594None
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less50$5,771$56
Return visit (30+ min)43$5,228$95
Injection of additional new drug or substance into vein79$4,981$13
Long return visit (40+ min)31$4,926$145
Administration of additional new drug or substance into vein, 1 hour or less27$4,294$57
Injection of drug or substance under skin or into muscle102$3,707$12
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count215$3,607$8
Injection of drug or substance into vein27$1,606$33
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle20$1,444$31
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less28$1,335$25
Infusion into a vein for therapy, prevention, or diagnosis, each additional hour17$1,248$18
Infusion into a vein for hydration, 31-60 minutes14$1,217$28
Administration of chemotherapy into vein, each additional hour17$944$24
Injection, carboplatin, 50 mg16$635None
Injection, fosaprepitant, 1 mg18$635None
Injection, palonosetron hcl, 25 mcg24$456None
Injection, zoledronic acid, 1 mg12$430None
Application of on-body injector for under skin injection14$410$16
Insertion of needle into vein for collection of blood sample33$389$9
Injection, paclitaxel, 1 mg12$370None
Infusion into a vein for hydration, each additional hour13$354$11
Injection, dexamethasone sodium phosphate, 1 mg65$161None
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg25$58None
Injection, diphenhydramine hcl, up to 50 mg44$54None
Injection, ondansetron hydrochloride, per 1 mg21$34None

Who their Medicare patients are

355 Original Medicare patients in 2024. Average age 76 · Under 65 8% · 85 and older 16% · Women 56% · Also on Medicaid 30% · Health risk score 2.02. Above the middle of the specialty; the typical nurse practitioner clinician is at 1.42.

Conditions among them: High blood pressure 75% · Chronic kidney disease 46% · Diabetes 40% · Cancer 39% · Coronary heart disease 29% · Heart failure 22% · Depression 22% · Atrial fibrillation 19% · COPD 17% · Stroke 12% · Dementia 8%.

The office billed $15,103,759, Medicare allowed $2,509,927 and paid $2,000,473; for 155,011 services of 99 kinds; $1,908,546 of it was for drugs given in the office and $91,928 for care.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
2024355155,011762.02$15,103,759$2,000,473
2023288108,429752.04$6,507,175$1,362,478
202210514,718761.99$1,219,929$270,030
202180175722.52$125,751$18,121
20201114764.55$4,590$938

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 25 services

Original Medicare services billed in 2023
Injection, denosumab, 1 mg21$52,783None
Injection, darbepoetin alfa, 1 microgram (non-esrd use)25$44,665None
Injection, ferric carboxymaltose, 1 mg25$23,607None
Administration of chemotherapy into vein, 1 hour or less50$23,524$117
Return visit (30+ min)48$7,619$86
Short return visit (20+ min)71$6,628$68
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less32$4,390$57
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count203$4,249$8
Administration of additional new drug or substance into vein, 1 hour or less18$3,786$57
Injection of additional new drug or substance into vein58$3,738$13
Long return visit (40+ min)15$2,348$138
Injection of drug or substance under skin or into muscle67$2,048$12
Drawing of blood for a medical problem16$1,686$89
Administration of chemotherapy into vein, each additional hour22$1,196$24
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less16$1,110$25
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle12$860$30
Infusion into a vein for therapy, prevention, or diagnosis, each additional hour14$841$18
Injection of drug or substance into vein19$722$33
Infusion into a vein for hydration, 31-60 minutes15$604$29
Injection, fosaprepitant, 1 mg11$457None
Injection, palonosetron hcl, 25 mcg18$393None
Infusion into a vein for hydration, each additional hour13$242$11
Injection, dexamethasone sodium phosphate, 1 mg47$102None
Injection, diphenhydramine hcl, up to 50 mg31$66None
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg15$40None

2022: 7 services

Original Medicare services billed in 2022
Administration of chemotherapy into vein, 1 hour or less19$4,586$121
Return visit (30+ min)22$2,534$101
Long return visit (40+ min)11$1,188$91
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count59$609$8
Injection of additional new drug or substance into vein11$586$14
Injection of drug or substance under skin or into muscle13$175$12
Injection, dexamethasone sodium phosphate, 1 mg11$17None

2021: 1 service

Original Medicare services billed in 2021
Long return visit (40+ min)69$16,683$111

Drugs they prescribed that Part D paid

$3,508,664

Pharmacies billed $3,508,664 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 7% of their Part D prescriptions (100 of 1,381) in 2024. Above the middle of the specialty; the typical nurse practitioner clinician is at 0%. Long-acting opioids: 28% of their opioid prescriptions.

1,033 generic and fewer than 11 brand-name prescriptions · $3,508,664 in drug cost · 12 antibiotic prescriptions to 12 people.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Revlimid31$594,503$19,178
Tagrisso14$523,782$37,413
Brukinsa36$480,248$13,340
Xtandi32$422,061$13,189
Pomalyst12$276,665$23,055
See all 37 drugs
Every Part D drug this clinician prescribed
Revlimid31$594,503$19,178
Tagrisso14$523,782$37,413
Brukinsa36$480,248$13,340
Xtandi32$422,061$13,189
Pomalyst12$276,665$23,055
Imbruvica22$245,465$11,157
Alecensa13$178,856$13,758
Vonjo13$158,472$12,190
Eliquis105$65,977$628
Xarelto19$19,420$1,022
Abiraterone Acetate14$3,067$219
Tamoxifen Citrate81$1,656$20
Prochlorperazine Maleate63$1,339$21
Entecavir12$1,221$102
Ondansetron46$1,190$26
Gabapentin59$1,183$20
Mirtazapine48$777$16
Hydrocodone-Acetaminophen36$706$20
Morphine Sulfate Er18$682$38
Hydroxyurea49$602$12
Letrozole34$572$17
Anastrozole21$563$27
Dexamethasone44$492$11
Acyclovir38$393$10
Oxycodone16$316$20
Ondansetron Odt16$270$17
Pantoprazole21$220$10
Folic Acid15$162$11
Prednisone34$143$4
Trazodone26$126$5
Alendronate28$107$4
Lorazepam27$94$3
Montelukast21$93$4
Alprazolam14$80$6
Allopurinol12$72$6
Amlodipine Besylate12$55$5
Venlafaxine Hcl Er12$42$4

Year by year

Part D prescribing by year
20241,3812797% (100)None$3,508,664
202399422412% (114)None$2,253,335
2022202899% (18)36%$905,632
202132610110% (32)None$743,551
202038811011% (41)None$1,180,766
20192417012% (28)20%$491,055

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 32 drugs

Part D drugs prescribed in 2023
Revlimid22$455,888$20,722
Xtandi24$342,851$14,285
Brukinsa14$212,052$15,147
Imbruvica17$211,033$12,414
Abiraterone Acetate13$63,423$4,879
Eliquis44$34,181$777
Orgovyx11$32,512$2,956
Imatinib Mesylate17$23,881$1,405
Xarelto11$13,451$1,223
Exemestane14$4,011$287
Tamoxifen Citrate68$2,322$34
Letrozole41$1,496$36
Hydrocodone-Acetaminophen50$1,449$29
Mirtazapine32$1,032$32
Entecavir12$917$76
Anastrozole24$854$36
Morphine Sulfate Er17$683$40
Gabapentin54$621$11
Prochlorperazine Maleate13$379$29
Oxycodone14$377$27
Prednisone29$348$12
Trazodone30$308$10
Hydroxyurea12$290$24
Pantoprazole20$284$14
Ondansetron11$247$22
Ondansetron Odt11$209$19
Acyclovir18$202$11
Dexamethasone20$163$8
Sertraline15$136$9
Alendronate12$135$11
Zolpidem12$121$10
Lorazepam28$121$4

2022: 3 drugs

Part D drugs prescribed in 2022
Tagrisso34$550,413$16,189
Eliquis18$9,976$554
Hydrocodone-Acetaminophen12$379$32

2021: 6 drugs

Part D drugs prescribed in 2021
Zenpep15$64,379$4,292
Eliquis22$11,269$512
Ondansetron25$1,043$42
Mirtazapine12$547$46
Oxycodone16$338$21
Lorazepam13$62$5

2020: 8 drugs

Part D drugs prescribed in 2020
Tagrisso24$356,802$14,867
Abiraterone Acetate17$162,899$9,582
Enoxaparin21$5,417$258
Dronabinol11$2,219$202
Ondansetron16$697$44
Oxycodone20$526$26
Hydrocortisone13$341$26
Prednisone25$133$5

2019: 4 drugs

Part D drugs prescribed in 2019
Tagrisso17$262,366$15,433
Prochlorperazine Maleate37$1,594$43
Ondansetron34$880$26
Dexamethasone23$674$29

Money from drug and device companies

$53 in 2025

Industry payments by year
202522None$53
202455None$113
2023811None$325
202233None$85
202112None$235

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
Daiichi SankyoEnhertu$30
1 payment
  • Meals for Enhertu · 2025-11-02 · $30
CelgeneReblozyl$23
1 payment
  • Meals for Reblozyl · 2025-06-27 · $23
See all 2 published payments
Every published payment
Daiichi SankyoMeals · 2025-11-02Enhertu$30
CelgeneMeals · 2025-06-27Reblozyl$23
See earlier years (2024, 2023, 2022, 2021)

2024: $113

Payments by company in 2024
CelgenePomalyst$29
1 payment
  • Meals for Pomalyst · 2024-03-19 · $29
EisaiLenvima$24
1 payment
  • Meals for Lenvima · 2024-06-18 · $24
Coherus BiosciencesUdenyca$23
1 payment
  • Meals for Udenyca · 2024-04-23 · $23
E.R. Squibb & Sons L.L.C.Opdivo$22
1 payment
  • Meals for Opdivo · 2024-02-06 · $22
PfizerBosulif$16
1 payment
  • Education for Bosulif · 2024-07-08 · $16

2023: $325

Payments by company in 2023
Daiichi SankyoInjectafer$98
4 payments
  • Meals · 2023-10-26 · $28
  • Meals for Injectafer · 2023-03-28 · $28
  • Meals for Injectafer · 2023-03-05 · $20
  • Meals for Injectafer · 2023-02-16 · $22
Takeda Pharmaceuticals U.S.A.Ninlaro$91
1 payment
  • Meals for Ninlaro · 2023-01-23 · $91
SeagenTukysa$27
1 payment
  • Meals for Tukysa · 2023-09-19 · $27
Pharmacyclics LLC An AbbVieImbruvica$26
1 payment
  • Meals for Imbruvica · 2023-10-18 · $26
Novartis PharmaceuticalsNone$24
1 payment
  • Meals · 2023-10-10 · $24
Bayer Healthcare PharmaceuticalsNubeqa$21
1 payment
  • Meals for Nubeqa · 2023-10-31 · $21
Coherus BiosciencesUdenyca$19
1 payment
  • Meals for Udenyca · 2023-03-10 · $19
NovocureOptune$18
1 payment
  • Meals for Optune · 2023-01-06 · $18

2022: $85

Payments by company in 2022
AstraZeneca Pharmaceuticals LPNone$50
1 payment
  • Meals · 2022-10-11 · $50
Daiichi SankyoInjectafer$22
1 payment
  • Meals for Injectafer · 2022-11-16 · $22
Coherus BiosciencesUdenyca$13
1 payment
  • Meals for Udenyca · 2022-12-15 · $13

2021: $235

Payments by company in 2021
Takeda Pharmaceuticals U.S.A.Exkivity$235
2 payments
  • Meals for Exkivity · 2021-12-14 · $118
  • Meals for Exkivity · 2021-12-14 · $118

Professional record

NPI
1447770359
Licence
CA 95016506
Video visits
Lists video visits
Gender
Female
More record details
Sole proprietor
No
Taxonomy
Nurse practitioner (363L00000X)
Mailing address
20055 Lake Chabot Rd Ste 130, Castro Valley, CA, 94546
NPI first listed
2017-06-21
NPI last updated
2024-02-01
NPI record certified
2024-02-01

This is when the NPI record was last certified, not a medical board exam.